Joel P. Bercu - Nonclinical Safety and Pathobiology (NSP), Gilead Sciences, Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 57 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Case to Support the Continued Use of Rifampin in Clinical Drug-Drug Interaction Studies

Joel P Bercu,David J Ponting, Sharon L Ripp,Krista L Dobo,Rheem A Totah,Jayaprakasam Bolleddula

Clinical pharmacology and therapeuticsno. 1 (2024): 34-37

Cited0Views0WOSBibtex

Analysis of Non-Mutagenic Substances in the Context of Drug Impurity Assessment – Few are Potent Toxicants

Catrin Hasselgren,Michelle Kenyon,Lennart T. Anger,Paul Cornwell, Eric Watt,Joel Bercu

Regulatory Toxicology and Pharmacology (2024): 105645-105645

Cited0Views0WOSBibtex

In Silico Assessment of Biomolecule Reactivity with Leachables

Candice Johnson, Douglas Kiehl, Piet Christiaens, Ferran Sancho Jodar, Ruud Cuyvers,Arianna Bassan,Lisa Beilke,Joel P Bercu, Thomas Costelloe,Kevin P Cross, Andrew Feilden, Ron Filler,

PDA journal of pharmaceutical science and technologyno. 3 (2024): 214-236

Cited0Views0WOSBibtex

Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls)

Melisa Masuda-Herrera, Hannah T Rosen,Anders Burild,Thomas Broschard,Troy Griffin, Tyler Bell,Jessica Graham,Jedd Hillegass, Penny Leavitt, Brian Huta, Trish Parris,Uma Bruen,

Regulatory toxicology and pharmacology : RTP (2023): 105494

Cited0Views0WOSBibtex

Occupational Toxicology in the Pharmaceutical Industry

David G. Dolan,Joel P. Bercu,Jessica C. Graham,Ester Lovšin Barle

Patty's Toxicologypp.1-39, (2023)

Cited0Views0Bibtex

Comparison of the transgenic rodent mutation assay, error corrected next generation duplex sequencing, and the alkaline comet assay to detect dose-related mutations following exposure to N-nitrosodiethylamine

Joel P. Bercu,Shaofei Zhang,Zhanna Sobol,Patricia A. Escobar,Phu Van,Maik Schuler

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2023): 503685-503685

Cited1Views0WOSBibtex

Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)

Joel P. Bercu,Melisa Masuda-Herrera,Alejandra Trejo-Martin, Priyanka Sura,Robert Jolly,Michelle Kenyon, Rob Thomas,David J. Ponting,David Snodin,Gregor Tuschl,Stephanie Simon, Kathleen De Vlieger,

Regulatory toxicology and pharmacology : RTP (2023): 105415

Cited4Views0WOSBibtex

Sensitization Assessment of Extractables and Leachables in Pharmaceuticals: ELSIE Database Analysis

Patricia Parris,Geraldine Whelan,Anders Burild,Jessica Whritenour,Uma Bruen,Joel Bercu,Courtney Callis,Martyn L Chilton,Jessica Graham,Esther Johann,Candice Johnson,Troy Griffin,

PDA journal of pharmaceutical science and technologypp.pdajpst.2022.012811-pdajpst.2022.012811, (2023)

Cited0Views0WOSBibtex

Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines

Alejandra Trejo-Martin,Joel P. Bercu,Andrew Thresher,Rachael E. Tennant, Robert F. Thomas,Kevin Cross,Andreas Czich, Kerstin Waese,John J. Nicolette,Joel Murray,Paul Sonders,Alison Kondratiuk,

Regulatory Toxicology and Pharmacology (2022): 105247-105247

Cited11Views0WOSBibtex

Framework for sensitization assessment of extractables and leachables in pharmaceuticals

Patricia Parris,Geraldine Whelan,Anders Burild,Jessica Whritenour,Uma Bruen,Joel Bercu,Courtney Callis,Jessica Graham,Esther Johann,Troy Griffin,Martin Kohan,Elizabeth A Martin,

CRITICAL REVIEWS IN TOXICOLOGY（2022）

Cited4Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn